BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 31472055)

  • 1. MicroRNA-143 as a new weapon against cancer: overview of the mechanistic insights and long non-coding RNA mediated regulation of miRNA-143 in different cancers.
    Farooqi AA; Qureshi MZ; Attar R; Alhewairini SS; Fayyaz S; Sabitaliyevich UY; Duisenbayevich TM; Alaaeddine N
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):1-5. PubMed ID: 31472055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-613: A novel tumor suppressor in human cancers.
    Mei J; Xu R; Hao L; Zhang Y
    Biomed Pharmacother; 2020 Mar; 123():109799. PubMed ID: 31877552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microRNA-410 in molecular oncology: A double edged sword.
    Wen R; Umeano AC; Essegian DJ; Sabitaliyevich UY; Wang K; Farooqi AA
    J Cell Biochem; 2018 Nov; 119(11):8737-8742. PubMed ID: 30086210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
    Müller S; Raulefs S; Bruns P; Afonso-Grunz F; Plötner A; Thermann R; Jäger C; Schlitter AM; Kong B; Regel I; Roth WK; Rotter B; Hoffmeier K; Kahl G; Koch I; Theis FJ; Kleeff J; Winter P; Michalski CW
    Mol Cancer; 2015 Apr; 14():94. PubMed ID: 25910082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
    Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
    Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Kisspeptin mediated signaling by non-coding RNAs in different cancers: the beginning of a new era.
    Farooqi AA; Attar R; Bageshlooyafshar B; Sabitaliyevich UY; Nurmurzayevich SB; Yelekenova AB; Gormus U
    Cell Mol Biol (Noisy-le-grand); 2019 Mar; 65(3):72-75. PubMed ID: 30942167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of NLRP3 by non-coding RNAs in different cancers: interplay between non-coding RNAs and NLRP3 in carcinogenesis and metastasis.
    Farooqi AA; Attar R; Tanriover G; Sabitaliyevich UY; Zhailganov A; Rabandiyarov M
    Cell Mol Biol (Noisy-le-grand); 2020 Dec; 66(8):47-51. PubMed ID: 34174977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic targeting of non-coding RNAs in cancer.
    Slaby O; Laga R; Sedlacek O
    Biochem J; 2017 Dec; 474(24):4219-4251. PubMed ID: 29242381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-221: biogenesis, function and signatures in human cancers.
    Abak A; Amini S; Sakhinia E; Abhari A
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3094-3117. PubMed ID: 29863255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs.
    Pilyugin M; Irminger-Finger I
    Int J Biochem Cell Biol; 2014 Sep; 54():356-67. PubMed ID: 25008968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA in carcinogenesis & cancer diagnostics: a new paradigm.
    Ahmad J; Hasnain SE; Siddiqui MA; Ahamed M; Musarrat J; Al-Khedhairy AA
    Indian J Med Res; 2013 Apr; 137(4):680-94. PubMed ID: 23703335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurine-upregulated gene 1 contributes to cancers through sponging microRNA.
    Zhou H; Gao Z; Wan F
    Acta Biochim Biophys Sin (Shanghai); 2019 Feb; 51(2):123-130. PubMed ID: 30590378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Analysis of microRNA Binding Site Distribution and microRNA-Mediated Gene Expression Repression of Oncogenes and Tumor Suppressor Genes.
    Tian S; Wang J; Zhang F; Wang D
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs and Long Non-coding RNAs as Novel Targets in Anti-cancer Drug Development.
    Çetinkaya M; Baran Y
    Curr Pharm Biotechnol; 2023; 24(7):913-925. PubMed ID: 35927824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC
    Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNAs as oncogenes and tumor suppressors.
    Zhang B; Pan X; Cobb GP; Anderson TA
    Dev Biol; 2007 Feb; 302(1):1-12. PubMed ID: 16989803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncmiRSRN: identification and analysis of long non-coding RNA related miRNA sponge regulatory network in human cancer.
    Zhang J; Liu L; Li J; Le TD
    Bioinformatics; 2018 Dec; 34(24):4232-4240. PubMed ID: 29955818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross talk between microRNA and coding cancer genes.
    Kunej T; Godnic I; Horvat S; Zorc M; Calin GA
    Cancer J; 2012; 18(3):223-31. PubMed ID: 22647358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-modulated autophagic signaling networks in cancer.
    Fu LL; Wen X; Bao JK; Liu B
    Int J Biochem Cell Biol; 2012 May; 44(5):733-6. PubMed ID: 22342941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.